TITLE:
Differentiation of Menstrual Blood Derived Stem Cell (MensSCs) to Hepatocyte-Liked Cell on Three Dimensional Nanofiberscaffold: Poly Caprolacton (PCL)
AUTHORS:
Farnaz Sani, Giti Borzooeian, Somayeh Kazemnejad, Sepideh Ebrahimi, Masoomeh Mohamadpour, Sayeh Khanjani, Mona Latifi, Seyed Mojtaba Hosseini, Mahin Salmannejad, Fatemeh Aleahmad, Hossein Mehraban Jahromi, Mahsa Sani
KEYWORDS:
Differentiation, Hepatocyte, Menstrual Blood, Stem Cell, 3D Cultures
JOURNAL NAME:
Journal of Biomedical Science and Engineering,
Vol.9 No.4,
March
29,
2016
ABSTRACT: Menstrual blood stem cells (MensSCs) have enormous potential as a source for cell replacement therapies. Since there is a major concern in utilization of nanofibers in tissue engineering of stem cells, we examined the potential of MensSCs to differentiate into hepatocytes, using different protocols and compare cells, with two-dimensional (2D) and three-dimensional (3D) culture systems. Cell characterization experiments of MensSCs have demonstrated that they are multipotent stem cells similar to mesenchymal stem cells, which can successfully differentiate into osteogenic and adipogenic lineages. The efficiency of the cells on the scaffold was appraised by scanning electron microscopy (SEM), MTT assay, and hematoxylin and eosin (H&E) staining. Thereafter, the differentiation protocols were developed by hepatocyte growth factor (HGF) and oncostatin M (OSM) with serum-supplemented or serum-free culture media up to 30 days. Immunofluorescence analysis and ELISA assay revealed the expression of albumin (ALB) in differentiated cells. Hepatocyte-like cells expressed liver-specific gene such as albumin(ALB), α-fetoprotein (AFP), tyrosine aminotransferase (TAT) and cytochrome P450 subunit 7a1 (Cyp7a1) at mRNA levels. In conclusion, the evidences presented in this study show that the nanofiber scaffold and MensSCs may provide a source of differentiated cells for treatment of liver diseases.